A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice

Hepatology

Volumn 37, Issue 4, 2003, Pages 887-892

  Pelletier, Gilles ^a   Roulot, Dominique ^b   Davion, Thierry ^c   Masliah, Claude ^d   Causse, Xavier ^e,j   Oberti, Frédéric ^f   Raabe, Jean Jacques ^g   Van Lemmens, Claire ^h   Labadie, Hélène ⁱ   Serfaty, Lawrence ^j,k   Capron, J P ^l   Levy, S ^l   Cale P ^l   Miguet, J P ^l   Beaugrand, M Bondy ^l   Grimbert, S ^l   Dao, T ^l   Chaput, J C ^l   Naveau, S ^l   Cadranel, J F ^l   Chousterman, M ^l   Hagege H ^l   Buffet, C ^l   Dewailly, A ^l   Paris, J C ^l   Raabe, J J ^l   Chapoutot, C ^l   Larrey, D ^l   Poupon, R ^k   Grange J D ^l   Pariente, A ^l   Morichau Beauchant, M ^l   Audigier, C ^l   Coppere, H ^l   Ink, O ^l   Doffoel, M ^l   Larricq, J ^l   more..

^a BICÊTRE HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c Centre Hospitalier de LENS   (France)

^d HÔTEL DIEU   (France)

^e CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g Bon Secours Hospital   (France)

^h UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁱ DELAFONTAINE HOSPITAL   (France)

^j HÔPITAL SAINT ANTOINE   (France)

^k HÔPITAL TENON   (France)

^l St Antoine Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BILIRUBIN; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 0037382139     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50118     Document Type: Article

References (25)

1. Poupon RE, Poupon R, Balkau B, and the UDCA-PBC study group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
2. Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. HEPATOLOGY 2000;32:1196-1199.
3. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. HEPATOLOGY 2002;36:525-531.
4. Trauner M, Graziadei IW. Mechanisms of action and therapeutic application of ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacol Ther 1999;13:979-995.
5. Heuman DM. Hepatoprotective properties of ursodesoxycholic acid. Gastroenterology 1993;104:1865-1869.
6. Salen G, Bata AK. Bile acids abnormalities in cholestatic liver diseases. Clin Gastrointest NA 1999;28:173-193.
7. Poynard T, Zourabichvili O, Hilpert G, Naveau S, Poitrine A, Benatar C, Chaput J-C. Prognostic value of total serum bilirubin/γ glutamyl transpeptidase ratio in cirrhotic patients. HEPATOLOGY 1984;4:324-327.
8. Powell WJ, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968;44:406-420.
9. Saunders JB, Walters JRF, Davies P, Paton A. A 20 year prospective study of cirrhosis. Br J Med 1981;282:263-266.
10. Blendis LM. The treatment of alcoholic liver disease. Aliment Pharmacol Ther 1992;6:541-548.
11. Ramond MJ, Rueff B, Benhamou JP. Medical treatment for alcoholic liver disease. Baillière's Clin Gastroenterol 1993;7:697-716.
12. Mullen KD, Dasarathy S. Potential new therapies for alcoholic liver disease. Clin Liver Dis 1998;2:851-881.
13. Ramond MJ, Poynard T, Rueff B, Mathurin P, Théodore C, Chaput JC, Benhamou JP. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-512.
14. Christensen E, Glund C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995;37: 113-118.
15. Mathurin P, Mendenhall CL, Carithers RL, Ramond MJ, Maddrey WC, Garstride P, Rueff B, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trial of corticosteroids in severe AH. J Hepatol 2002;36:480-487.
16. Osborn EC, Wootton IDP, Da Silva LC, Sherlock S. Serum-bile-acid levels in liver disease. Lancet 1959;2:1049-1053.
17. Makino I, Nakagawa S, Mashimo K. Conjugated and unconjugated serum bile acid levels in patients with hepatobiliary diseases. Gastroenterology 1969;56:1033-1039.
18. Barnes S, Gallo GA, Trash DB, Morris JS. Diagnostic value of serum bile acid estimations in liver diseases. J Clin Pathol 1975;28:506-509.
19. Trinchet JC, Gerhardt MF, Balkan B, Munz C, Poupon RE. Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features. J Hepatol 1994;21:235-240.
20. Plevris JN, Hayes PC, Bouchier IAD. Ursodeoxycholic acid in the treatment of alcoholic liver disease. Eur J Gastroenterol Hepatol 1991;3:653-656.
21. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.
22. Poupon RE, Bonnard AM, Queneau PE, Trépo C, Zarski JP, Vetter D, Raabe JJ, et al. Randomized trial of interferon alfa plus ursodeoxycholic acid versus interferon plus placebo in patient with chronic hepatitis C resistant to interferon. Scand J Gastroenterol 2000;35:642-649.
23. Poupon RE, Chrétien Y, Poupon R, Paumgartner G. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy. HEPATOLOGY 1993;17:599-604.
24. Galle PR, Theilmann LL, Raedsch R, Otto G, Stiehl A. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. HEPATOLOGY 1990;12:486-491.
25. Schölmerich J, Becher M-S, Schmidt K, Schubert R, Kremer B, Feldhaus S, Gerok W. Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties. Studies on isolated hepatocytes and lipid membrane vesicles. HEPATOLOGY 1984;4:661-666.